Search Ontology:
ChEBI
alogliptin
- Term ID
- CHEBI:72323
- Synonyms
-
- 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile
- alogliptin
- alogliptina
- alogliptine
- alogliptinum
- Definition
- A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes.
- References
-
- cas:850649-61-5
- drugcentral:4340
- patent:EP1970063
- patent:US2007066635
- patent:US2009275750
- patent:WO2008028914
- patent:WO2009022009
- patent:WO2010072680
- pubmed:20040339
- pubmed:21205126
- pubmed:21397040
- pubmed:21431099
- pubmed:21558879
- pubmed:21595274
- pubmed:21595275
- pubmed:21682833
- pubmed:21733058
- pubmed:21806314
- pubmed:22106975
- pubmed:22162539
- pubmed:22237690
- pubmed:22249941
- pubmed:22296609
- pubmed:22419732
- pubmed:22429011
- pubmed:22512582
- pubmed:22583697
- pubmed:22651127
- pubmed:22832924
- pubmed:23220949
- pubmed:23289982
- pubmed:23298374
- reaxys:10587993
- wikipedia.en:Alogliptin
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alogliptin
Phenotype where environments contain alogliptin
Phenotype modified by environments containing alogliptin
Phenotype affecting alogliptin
Human Disease Model